Vivani Medical Stock (NASDAQ:VANI)

Revenue Financials Chart

Previous Close

$1.18

52W Range

$1.01 - $7.80

50D Avg

$1.27

200D Avg

$1.37

Market Cap

$69.30M

Avg Vol (3M)

$130.35K

Beta

3.52

Div Yield

-

VANI Company Profile

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

36

IPO Date

Nov 19, 2014

Website

VANI Performance

VANI Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	-	-
Operating Income	$-26.96M	$-21.24M	$-13.32M
Net Income	$-25.65M	$-6.54M	$-12.13M
EBITDA	$-26.96M	$-27.74M	$-13.62M
Basic EPS	$-0.50	$-0.17	$-0.37
Diluted EPS	$-0.50	$-0.17	$-0.37

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q4 19Mar 19, 20 | 4:30 PM

Q3 19Nov 15, 19 | 4:30 PM

Q2 19Aug 07, 19 | 4:30 PM

Peer Comparison

Ticker	Company
PHVS	Pharvaris N.V.
HCWB	HCW Biologics Inc.
RLYB	Rallybio Corporation
ANEB	Anebulo Pharmaceuticals, Inc.
PMVP	PMV Pharmaceuticals, Inc.
TYRA	Tyra Biosciences, Inc.
ANTX	AN2 Therapeutics, Inc.
TRDA	Entrada Therapeutics, Inc.
PEPG	PepGen Inc.